Quarter Financials

BiondVax Pharmaceuticals Ltd. (BVXV)

$1.36

+0.01 (+0.74%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3
Net Income -4-4610-12-8-11-9
Dividend Paid -------24-
Retained Earnings -123-119-116-383-387-374-365-354

PPE Schedule

Year 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3
Capital Expenditure -0-0-0--0-1-0-0
Net PPE 1212134444454444

Intangible and Goodwill Schedule

Year 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3
New Purchases --------
Intangible and Goodwill --------